Nov 9 (Reuters) - Medibio Ltd (MEB) :
- PROVIDES UPDATE ON FDA PROCESS
- FDA REQUESTS CLARIFICATION ON 11 KEY POINTS OF THE DE NOVO APPLICATION
- WHIL DE NOVO APPLICATION WILL TAKE LONGER THAN ORIGINALLY ANTICIPATED, FULL MEDIBIO TEAM WILL IMMEDIATELY PURSUE 510K APPLICATION
